Suppr超能文献

诊断和治疗监测结核病的生物标志物:综述。

Biomarkers in diagnosing and therapeutic monitoring of tuberculosis: a review.

机构信息

Department of Respiratory Medicine, Chettinad Hospital and Research Institute, Chettinad Academy of Research and Education, Kelambakkam, Tamil Nadu, India.

Faculty of Allied Health Sciences, Chettinad Hospital and Research Institute, Chettinad Academy of Research and Education, Kelambakkam, Tamil Nadu, India.

出版信息

Ann Med. 2024 Dec;56(1):2386030. doi: 10.1080/07853890.2024.2386030. Epub 2024 Aug 3.

Abstract

Tuberculosis (TB) continues to pose a significant health challenge worldwide, emphasizing the importance of prompt diagnosis and efficient monitoring of treatment outcomes for effective disease control. Biomarkers have become increasingly important in the realm of TB diagnoses and treatment. The objective of this comprehensive review is to examine the present state of biomarkers employed in the diagnosis of TB, monitoring the response to treatment, and predicting treatment outcomes. In this study, we undertake a comprehensive examination of the diverse biomarkers utilized in TB diagnoses, spanning molecular, immunological, and other novel methodologies. Furthermore, we examine the potential of biomarkers in the context of therapeutic monitoring, assessment of treatment effectiveness, and anticipation of drug resistance. Additionally, this paper presents future prospects regarding the utilization of biomarkers in the therapy of tuberculosis.

摘要

结核病(TB)仍然是全球范围内的重大健康挑战,强调了及时诊断和有效监测治疗结果对于有效控制疾病的重要性。生物标志物在结核病的诊断和治疗中变得越来越重要。本综述的目的是检查用于诊断结核病、监测治疗反应和预测治疗结果的生物标志物的现状。在这项研究中,我们全面检查了用于结核病诊断的各种生物标志物,包括分子、免疫和其他新方法。此外,我们还研究了生物标志物在治疗监测、治疗效果评估和耐药性预测方面的潜力。此外,本文还介绍了生物标志物在结核病治疗中的未来应用前景。

相似文献

1
Biomarkers in diagnosing and therapeutic monitoring of tuberculosis: a review.
Ann Med. 2024 Dec;56(1):2386030. doi: 10.1080/07853890.2024.2386030. Epub 2024 Aug 3.
2
IP-10 response to RD1 antigens might be a useful biomarker for monitoring tuberculosis therapy.
BMC Infect Dis. 2011 May 19;11:135. doi: 10.1186/1471-2334-11-135.
3
Tuberculosis Treatment Monitoring and Outcome Measures: New Interest and New Strategies.
Clin Microbiol Rev. 2022 Sep 21;35(3):e0022721. doi: 10.1128/cmr.00227-21. Epub 2022 Mar 21.
4
Current status and future trends in the diagnosis and treatment of drug-susceptible and multidrug-resistant tuberculosis.
J Infect Public Health. 2014 Mar-Apr;7(2):75-91. doi: 10.1016/j.jiph.2013.09.001. Epub 2013 Nov 9.
5
Cytokines for monitoring anti-tuberculous therapy: A systematic review.
Tuberculosis (Edinb). 2015 May;95(3):217-28. doi: 10.1016/j.tube.2015.01.003. Epub 2015 Jan 30.
8
The Global Landscape of Tuberculosis Therapeutics.
Annu Rev Med. 2019 Jan 27;70:105-120. doi: 10.1146/annurev-med-040717-051150. Epub 2018 Nov 7.

引用本文的文献

1
Recent advancements in drug development for pulmonary tuberculosis.
Arch Microbiol. 2025 Aug 30;207(10):245. doi: 10.1007/s00203-025-04415-y.

本文引用的文献

1
Diagnostic value of the neutrophil lymphocyte ratio in discrimination between tuberculosis and bacterial community acquired pneumonia: A -analysis.
J Clin Tuberc Other Mycobact Dis. 2023 Aug 23;33:100395. doi: 10.1016/j.jctube.2023.100395. eCollection 2023 Dec.
3
Drivers determining tuberculosis disease screening yield in four European screening programmes: a comparative analysis.
Eur Respir J. 2023 Oct 12;62(4). doi: 10.1183/13993003.02396-2022. Print 2023 Oct.
5
WHO's Global Tuberculosis Report 2022.
Lancet Microbe. 2023 Jan;4(1):e20. doi: 10.1016/S2666-5247(22)00359-7. Epub 2022 Dec 12.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验